Metabolic Modeling Predicts Unique Drug Targets in Lyme Disease Pathogen B. burgdorferi – TUSM’s Peter Gwynne, PhD
February 23, 2023
We were pleased to hear from Bryan Lenneman, Ph.D., today on “Engineering Phages as Novel Antimicrobials Targeting Gram-Negative Pathogens.” Dr. Lenneman is a Research Fellow at Massachusetts General Hospital whose research interests include utilizing synthetic biology to develop novel therapeutics against diseases associated with dysbiosis of the human gut microbial community.
Engineering Phages as Novel Antimicrobials Targeting Gram-Negative Pathogens – Massachusetts General Hospital’s Bryan Lenneman, Ph.D.
March 30, 2023
MGH Research Fellow Bryan Lenneman, PhD, is interested in utilizing synthetic biology to develop novel therapeutics against diseases associated with dysbiosis of the human gut microbial community.
Diagnostic Stewardship as a Tool for Antimicrobial Stewardship – Tufts Medical Center’s Shira Doron, MD
October 26, 2023
Levy CIMAR’s own Shira Doron, MD, presented for this month’s Science Seminar on the topic of “Diagnostic Stewardship as a Tool for Antimicrobial Stewardship.” Dr. Doron is a widely recognized expert in the fields of antimicrobial and diagnostic stewardship, and among her many titles, is Chief Infection Control Officer for Tufts Medicine. There, she Infection Control and Antimicrobial Stewardship.
CIMAR Joins the Battle Against AMR with Collaborative and Brainstorming Workshop
January 21, 2019
The Tufts Center for Integrated Management of Antimicrobial Resistance (CIMAR) hosted its first event last month to introduce the Center to the local scientific community and to offer a platform for investigators and clinicians to showcase their research and promote collaborations. CIMAR aims to address the rise and spread of antimicrobial resistance (AMR), and we believe our faculty possess the myriad unique skillsets needed to lead this fight. Roughly 700,000 human deaths are attributable to AMR each year globally, and if trends continue, AMR could contribute to a total of 350 million deaths by 2050.
Transcriptional Profiling for Infectious Disease Diagnostics and Discovery – Massachusetts General Hospital’s Roby Bhattacharyya, MD, PhD
May 25, 2023
Massachusetts General Hospital’s Roby Bhattacharyya, MD, PhD, presented today on “Transcriptional Profiling for Infectious Disease Diagnostics and Discovery” for the Levy CIMAR’s May 25th Science Lunch, our last seminar of the ’22-’23 season. Dr. Bhattacharyya is an Assistant Professor in the Infectious Diseases Division at MGH as well as an Associate Member of the Broad Institute and an Assistant Professor at Harvard Medical School.
Discovery and Development of Novel Antimalarials and Their Use as Chemical Tools to Discover New Biology of the Malaria Parasite – WEHI’s Professor Alan F. Cowman
September 28, 2023
The Levy CIMAR kicked off its 2023-2024 seminar season today with a talk from world-renowned Professor Alan F. Cowman, who among his many roles is acting Director of Australia’s Walter and Eliza Hall Institute of Medical Research (WEHI). An internationally acclaimed expert in malaria research, Prof. Cowman heads a laboratory at WEHI where he and his team aim to advance the understanding of how malaria-causing parasites invade human cells.
Superbugs From Their Backyards and Beyond: Brockton High Schoolers Present “Tiny Earth” Findings to Levy CIMAR; Tufts Community
May 9, 2023
CIMAR hosted 33 students from Boston-area Brockton High School last week for a rare educational and networking opportunity. Students presented posters depicting original experiments and data on antimicrobial resistance to a wide audience of Tufts University and Tufts Medical Center members.
- Metabolic Modeling Predicts Unique Drug Targets in Lyme Disease Pathogen B. burgdorferi – TUSM’s Peter Gwynne, PhDFebruary 23, 2023
- Engineering Phages as Novel Antimicrobials Targeting Gram-Negative Pathogens – Massachusetts General Hospital’s Bryan Lenneman, Ph.D.March 30, 2023
- Diagnostic Stewardship as a Tool for Antimicrobial Stewardship – Tufts Medical Center’s Shira Doron, MDOctober 26, 2023
- CIMAR Joins the Battle Against AMR with Collaborative and Brainstorming WorkshopJanuary 21, 2019
- Transcriptional Profiling for Infectious Disease Diagnostics and Discovery – Massachusetts General Hospital’s Roby Bhattacharyya, MD, PhDMay 25, 2023